APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 0.75 mg modified release tablet blister pack Australia - inglés - Department of Health (Therapeutic Goods Administration)

apo-pramipexole er pramipexole dihydrochloride monohydrate 0.75 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 0.75 mg - tablet, modified release - excipient ingredients: hypromellose; magnesium stearate; calcium hydrogen phosphate; silicon dioxide - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet blister pack Australia - inglés - Department of Health (Therapeutic Goods Administration)

apo-pramipexole er pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 4.5 mg - tablet, modified release - excipient ingredients: silicon dioxide; magnesium stearate; hypromellose; calcium hydrogen phosphate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet blister pack Australia - inglés - Department of Health (Therapeutic Goods Administration)

apo-pramipexole er pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 2.25 mg - tablet, modified release - excipient ingredients: silicon dioxide; magnesium stearate; hypromellose; calcium hydrogen phosphate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 1.5 mg modified release tablet blister pack Australia - inglés - Department of Health (Therapeutic Goods Administration)

apo-pramipexole er pramipexole dihydrochloride monohydrate 1.5 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: silicon dioxide; hypromellose; magnesium stearate; calcium hydrogen phosphate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

Pramipexole Aurobindo 0.088mg Tablets Malta - inglés - Medicines Authority

pramipexole aurobindo 0.088mg tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - pramipexole - tablet - pramipexole 0.088 mg - anti-parkinson drugs

Pramipexole Aurobindo 0.18mg Tablets Malta - inglés - Medicines Authority

pramipexole aurobindo 0.18mg tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - pramipexole - tablet - pramipexole 0.18 mg - anti-parkinson drugs

Pramipexole Aurobindo 0.35mg Tablets Malta - inglés - Medicines Authority

pramipexole aurobindo 0.35mg tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - pramipexole - tablet - pramipexole 0.35 mg - anti-parkinson drugs

Pramipexole Aurobindo 0.7mg Tablets Malta - inglés - Medicines Authority

pramipexole aurobindo 0.7mg tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - pramipexole - tablet - pramipexole 0.7 mg - anti-parkinson drugs

Pramipexole Aurobindo 1.1mg Tablets Malta - inglés - Medicines Authority

pramipexole aurobindo 1.1mg tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - pramipexole - tablet - pramipexole 1.1 mg - anti-parkinson drugs

PRAMIPEXOLE XR GP pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack Australia - inglés - Department of Health (Therapeutic Goods Administration)

pramipexole xr gp pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 3 mg - tablet, modified release - excipient ingredients: hypromellose; calcium hydrogen phosphate; magnesium stearate; silicon dioxide - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.